hrcak mascot   Srce   HID

Pregledni rad

Prednosti humanog epididimalog proteina (HE4) u odnosu na tradicionalno korištene tumorske markere u ginekološkoj onkologiji

Zvjezdana Špacir Prskalo   ORCID icon orcid.org/0000-0002-4519-8183 ; Department of Medical Biochemistry in Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Mihaela Gaće ; Department of Medical Biochemistry in Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Sanja Dobrijević ; Department of Medical Biochemistry in Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ljiljana Mayer ; Department of Medical Biochemistry in Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

Puni tekst: engleski, pdf (154 KB) str. 9-14 preuzimanja: 70* citiraj
APA 6th Edition
Špacir Prskalo, Z., Gaće, M., Dobrijević, S. i Mayer, Lj. (2015). Benefits human epidydimis protein (HE4) compared to traditional used tumor markers in gynecological oncology. Libri Oncologici, 43 (1-3), 9-14. Preuzeto s https://hrcak.srce.hr/189799
MLA 8th Edition
Špacir Prskalo, Zvjezdana, et al. "Benefits human epidydimis protein (HE4) compared to traditional used tumor markers in gynecological oncology." Libri Oncologici, vol. 43, br. 1-3, 2015, str. 9-14. https://hrcak.srce.hr/189799. Citirano 23.07.2019.
Chicago 17th Edition
Špacir Prskalo, Zvjezdana, Mihaela Gaće, Sanja Dobrijević i Ljiljana Mayer. "Benefits human epidydimis protein (HE4) compared to traditional used tumor markers in gynecological oncology." Libri Oncologici 43, br. 1-3 (2015): 9-14. https://hrcak.srce.hr/189799
Harvard
Špacir Prskalo, Z., et al. (2015). 'Benefits human epidydimis protein (HE4) compared to traditional used tumor markers in gynecological oncology', Libri Oncologici, 43(1-3), str. 9-14. Preuzeto s: https://hrcak.srce.hr/189799 (Datum pristupa: 23.07.2019.)
Vancouver
Špacir Prskalo Z, Gaće M, Dobrijević S, Mayer Lj. Benefits human epidydimis protein (HE4) compared to traditional used tumor markers in gynecological oncology. Libri Oncologici [Internet]. 2015 [pristupljeno 23.07.2019.];43(1-3):9-14. Dostupno na: https://hrcak.srce.hr/189799
IEEE
Z. Špacir Prskalo, M. Gaće, S. Dobrijević i Lj. Mayer, "Benefits human epidydimis protein (HE4) compared to traditional used tumor markers in gynecological oncology", Libri Oncologici, vol.43, br. 1-3, str. 9-14, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/189799. [Citirano: 23.07.2019.]

Sažetak
Rak jajnika je globalni javnozdravstveni problem radi visoke učestalosti i smrtnosti. Jedan od razloga za to je nedostatak jasnih kliničkih simptoma bolesti. Drugi razlog je praktički nepostojanje metode probira za rak jajnika. Donedavno, jedini rutinski koristan tumorski marker za karcinom jajnika bio je CA125. Određivanje razine HE4, zajedno s CA125 i izračun
indeksa ROMA pogodna je metoda poboljšanja dijagnostike primarnog otkrivanja raka jajnika. Mjerenje serumskog HE4 korisno je u razlikovanju benignih ginekoloških bolesti od karcinoma jajnika.

Ključne riječi
rak jajnika; CEA 125; HE4 (Humani epidimelni protein); ROMA index

Hrčak ID: 189799

URI
https://hrcak.srce.hr/189799

[engleski]

Posjeta: 120 *